You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Breast Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 2 of 2 | Results 11 - 14 of 14

Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

Cancer - Breast, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Cancer, Cancer - Breast

Baystate Breast and Wellness Center, 100 Wason Avenue, 3rd Floor, Springfield, MA

Active

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without your cancer returning.  The current standard treatment after chemotherapy is hormone treatment alone. The combination of hormone-treatment and everolimus is experimental in patients with breast cancer.

 

Cancer - Breast, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

This study evaluates whether the addition of chestwall + regional nodal XRT after mastectomy or breast + regional nodal XRT after breast conserving surgery will significantly reduce the rate of events for invasive breast cancer recurrence-free interval (IBC-RFI) in patients who present with histologically positive axillary nodes but convert to histologically negative axillary nodes following neoadjuvant chemotherapy.

Cancer - Breast, Surgery

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting
Page 2 of 2 | Results 11 - 14 of 14